These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 30841441)
1. An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases. Wojtunik-Kulesza K; Oniszczuk A; Waksmundzka-Hajnos M Biomed Pharmacother; 2019 Mar; 111():1277-1289. PubMed ID: 30841441 [TBL] [Abstract][Full Text] [Related]
3. Glycation in Parkinson's disease and Alzheimer's disease. Vicente Miranda H; El-Agnaf OM; Outeiro TF Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341 [TBL] [Abstract][Full Text] [Related]
4. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics. Belaidi AA; Bush AI J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340 [TBL] [Abstract][Full Text] [Related]
5. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases. Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589 [TBL] [Abstract][Full Text] [Related]
6. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Gaeta A; Hider RC Br J Pharmacol; 2005 Dec; 146(8):1041-59. PubMed ID: 16205720 [TBL] [Abstract][Full Text] [Related]
7. Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways. Majd S; Power JH; Grantham HJ BMC Neurosci; 2015 Oct; 16():69. PubMed ID: 26499115 [TBL] [Abstract][Full Text] [Related]
8. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Vella LJ; Hill AF; Cheng L Int J Mol Sci; 2016 Feb; 17(2):173. PubMed ID: 26861304 [TBL] [Abstract][Full Text] [Related]
9. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Hashimoto M; Rockenstein E; Crews L; Masliah E Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050 [TBL] [Abstract][Full Text] [Related]
10. Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease. Antonyová V; Kejík Z; Brogyányi T; Kaplánek R; Pajková M; Talianová V; Hromádka R; Masařík M; Sýkora D; Mikšátková L; Martásek P; Jakubek M DNA Repair (Amst); 2020; 91-92():102871. PubMed ID: 32502755 [TBL] [Abstract][Full Text] [Related]
11. Metals in Alzheimer's and Parkinson's diseases. Barnham KJ; Bush AI Curr Opin Chem Biol; 2008 Apr; 12(2):222-8. PubMed ID: 18342639 [TBL] [Abstract][Full Text] [Related]
12. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies. Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Jiang T; Sun Q; Chen S Prog Neurobiol; 2016 Dec; 147():1-19. PubMed ID: 27769868 [TBL] [Abstract][Full Text] [Related]
14. Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Peng B; Yang Q; B Joshi R; Liu Y; Akbar M; Song BJ; Zhou S; Wang X Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230811 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae. Pimentel C; Batista-Nascimento L; Rodrigues-Pousada C; Menezes RA Oxid Med Cell Longev; 2012; 2012():132146. PubMed ID: 22701754 [TBL] [Abstract][Full Text] [Related]
16. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases. Atsmon-Raz Y; Miller Y ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553 [TBL] [Abstract][Full Text] [Related]
17. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944 [TBL] [Abstract][Full Text] [Related]
18. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases. Williams SM; Schulz P; Sierks MR Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448 [TBL] [Abstract][Full Text] [Related]
19. [The role of aluminum and lead in the development of Alzheimer's and Parkinson's diseases]. Salkov VN; Khudoerkov RM Arkh Patol; 2021; 83(3):56-61. PubMed ID: 34041898 [TBL] [Abstract][Full Text] [Related]
20. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases. Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]